Literature DB >> 3489290

Measuring health in rheumatic disorders by means of a Swedish version of the sickness impact profile. Results from a population study.

M Sullivan, M Ahlmén, B Archenholtz, G Svensson.   

Abstract

A technique for assessing the overall consequences of disease is introduced, comprising a Swedish version of a behaviour-based measure, the Sickness Impact Profile (SIP). Measurement characteristics of the profile are defined in an epidemiological study of 147 women with rheumatic disorders. The drop-out rate was 7.5%. Cross-cultural evidence of the validity of the SIP was obtained in this study. Test-retest reliability was substantial. A high level of validity of the Swedish version was demonstrated, as assessed by hypothesized significant relationships with selected functional, psychological, and social correlates. The profile was able to describe the various sickness impacts in a specific and sensitive manner. In the epidemiological setting, the subscales representing Ambulation, Body care and movement, Emotional behaviour, Social interaction, Sleep and rest, Home management and Recreation and pastimes, all showed discriminatory capacity. The categories Mobility, Alertness behaviour, Communication, Work, and Eating discriminated less well. The response pattern was recognizably related to rheumatic complaints, emphasizing a broader applicability of this scale in rheumatology.

Entities:  

Mesh:

Year:  1986        PMID: 3489290     DOI: 10.3109/03009748609102088

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  15 in total

Review 1.  A comparative review of generic quality-of-life instruments.

Authors:  S J Coons; S Rao; D L Keininger; R D Hays
Journal:  Pharmacoeconomics       Date:  2000-01       Impact factor: 4.981

2.  The SIP68: an abbreviated sickness impact profile for disability outcomes research.

Authors:  Upasana Nanda; Patricia M McLendon; Elena M Andresen; Eric Armbrecht
Journal:  Qual Life Res       Date:  2003-08       Impact factor: 4.147

Review 3.  A review of the progress towards developing health-related quality-of-life instruments for international clinical studies and outcomes research.

Authors:  R T Anderson; N K Aaronson; M Bullinger; W L McBee
Journal:  Pharmacoeconomics       Date:  1996-10       Impact factor: 4.981

4.  Technology assessment using the association between outcome measures and patterns of illness severity.

Authors:  R T Almeida; H Hjortswang; M Ström; S Almer; J Persson
Journal:  Med Biol Eng Comput       Date:  1997-07       Impact factor: 2.602

5.  Quality of life in predialytic uremic patients.

Authors:  B Klang; H Björvell; N Clyne
Journal:  Qual Life Res       Date:  1996-02       Impact factor: 4.147

6.  The life situations of patients with primary antibody deficiency untreated or treated with subcutaneous gammaglobulin infusions.

Authors:  A Gardulf; H Björvell; R Gustafson; L Hammarström; C I Smith
Journal:  Clin Exp Immunol       Date:  1993-05       Impact factor: 4.330

7.  Smallest real difference, a link between reproducibility and responsiveness.

Authors:  H Beckerman; M E Roebroeck; G J Lankhorst; J G Becher; P D Bezemer; A L Verbeek
Journal:  Qual Life Res       Date:  2001       Impact factor: 4.147

Review 8.  Critical review of the international assessments of health-related quality of life.

Authors:  R T Anderson; N K Aaronson; D Wilkin
Journal:  Qual Life Res       Date:  1993-12       Impact factor: 4.147

9.  Qualify of life and palliation predict survival in patients with chronic alveolar hypoventilation and nocturnal ventilatory support.

Authors:  Jan Olofson; Catharina Dellborg; Marianne Sullivan; Bengt Midgren; Oscar Caro; Bengt Bergman
Journal:  Qual Life Res       Date:  2009-02-14       Impact factor: 4.147

10.  Change and status in quality of life in patients with rheumatoid arthritis.

Authors:  P Bendtsen; J O Hörnquist
Journal:  Qual Life Res       Date:  1992-10       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.